# Thyroid and Glucose and Energy Metabolism

> **NCT00106119** · PHASE2 · COMPLETED · sponsor: **National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)** · enrollment: 18 (actual)

## Conditions studied

- Thyroid Diseases

## Interventions

- **DRUG:** Liothyronine and Levothyroxine

## Key facts

- **NCT ID:** NCT00106119
- **Lead sponsor:** National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-03
- **Primary completion:** 2013-11
- **Final completion:** 2013-11
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2015-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00106119

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00106119, "Thyroid and Glucose and Energy Metabolism". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00106119. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
